FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992418905> ?p ?o ?g. }

• W1992418905 endingPage "694" @default.
• W1992418905 startingPage "693" @default.
• W1992418905 abstract "American Journal of HematologyVolume 83, Issue 9 p. 693-694 CommentaryFree Access Prospects and perils of retrospective risk assessment of erythropoiesis-stimulating agents† David P. Steensma, Corresponding Author David P. Steensma [email protected] Division of Hematology, Mayo Clinic, Rochester, MinnesotaMayo Clinic, 200 First Street SW, Rochester, MN 55905Search for more papers by this author David P. Steensma, Corresponding Author David P. Steensma [email protected] Division of Hematology, Mayo Clinic, Rochester, MinnesotaMayo Clinic, 200 First Street SW, Rochester, MN 55905Search for more papers by this author First published: 12 June 2008 https://doi.org/10.1002/ajh.21244Citations: 6 † Conflict of interest: Nothing to report AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Katodritou E,Verrou E,Gastari V, et al. Erythropoiesis stimulating agents (ESA) are associated with reduced survival in patients with multiple myeloma. Am J Hematol, in press. 2 Bennett CL,Silver SM,Djulbegovic B, et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008; 299: 914– 924. 3 Kyle RA,Rajkumar SV. Epidemiology of the plasma-cell disorders. Best Pract Res Clin Haematol 2007; 20: 637– 664. 4 Baz R,Walker E,Choueiri TK, et al. Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma. Acta Haematol 2007; 117: 162– 167. 5 Prutchi-Sagiv S,Golishevsky N,Oster HS, et al. Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: Could it be beneficial in early disease? Br J Haematol 2006; 135: 660– 672. 6 Mittelman M,Zeidman A,Kanter P, et al. Erythropoietin has an anti-myeloma effect—A hypothesis based on a clinical observation supported by animal studies. Eur J Haematol 2004; 72: 155– 165. 7 Ludwig H,Pohl G,Osterborg A. Anemia in multiple myeloma. Clin Adv Hematol Oncol 2004; 2: 233– 241. 8 Ludwig H,Fritz E,Kotzmann H,Gisslinger H. Erythropoietin treatment of tumor-associated anemia in patients with multiple myeloma. Onkologie 1990; 13: 46– 49. 9 Oster W,Herrmann F,Gamm H, et al. Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. J Clin Oncol 1990; 8: 956– 962. 10 Durie BG,Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842– 854. 11 Greipp PR,San Miguel J,Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412– 3420. 12 Grimes DA,Schulz KF. Cohort studies: Marching towards outcomes. Lancet 2002; 359: 341– 345. 13 Huang J,Li CY,Mesa RA, et al. Risk factors for leukemic transformation in patients with primary myelofibrosis. Cancer 2008; 112: 2726– 2732. Citing Literature Volume83, Issue9September 2008Pages 693-694 ReferencesRelatedInformation" @default.
• W1992418905 created "2016-06-24" @default.
• W1992418905 creator A5077104483 @default.
• W1992418905 date "2008-09-01" @default.
• W1992418905 modified "2023-09-27" @default.
• W1992418905 title "Prospects and perils of retrospective risk assessment of erythropoiesis-stimulating agents" @default.
• W1992418905 cites W1822925937 @default.
• W1992418905 cites W1970111821 @default.
• W1992418905 cites W1982410732 @default.
• W1992418905 cites W2006382315 @default.
• W1992418905 cites W2028827702 @default.
• W1992418905 cites W2045865836 @default.
• W1992418905 cites W2120474651 @default.
• W1992418905 cites W2136899564 @default.
• W1992418905 cites W2138343003 @default.
• W1992418905 cites W2150250025 @default.
• W1992418905 doi "https://doi.org/10.1002/ajh.21244" @default.
• W1992418905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18615451" @default.
• W1992418905 hasPublicationYear "2008" @default.
• W1992418905 type Work @default.
• W1992418905 sameAs 1992418905 @default.
• W1992418905 citedByCount "7" @default.
• W1992418905 countsByYear W19924189052012 @default.
• W1992418905 countsByYear W19924189052018 @default.
• W1992418905 crossrefType "journal-article" @default.
• W1992418905 hasAuthorship W1992418905A5077104483 @default.
• W1992418905 hasBestOaLocation W19924189051 @default.
• W1992418905 hasConcept C126322002 @default.
• W1992418905 hasConcept C143998085 @default.
• W1992418905 hasConcept C161191863 @default.
• W1992418905 hasConcept C167135981 @default.
• W1992418905 hasConcept C194409129 @default.
• W1992418905 hasConcept C2776063141 @default.
• W1992418905 hasConcept C2776364478 @default.
• W1992418905 hasConcept C2778248108 @default.
• W1992418905 hasConcept C2778805511 @default.
• W1992418905 hasConcept C2779703530 @default.
• W1992418905 hasConcept C2781404941 @default.
• W1992418905 hasConcept C2993853449 @default.
• W1992418905 hasConcept C41008148 @default.
• W1992418905 hasConcept C512399662 @default.
• W1992418905 hasConcept C71924100 @default.
• W1992418905 hasConceptScore W1992418905C126322002 @default.
• W1992418905 hasConceptScore W1992418905C143998085 @default.
• W1992418905 hasConceptScore W1992418905C161191863 @default.
• W1992418905 hasConceptScore W1992418905C167135981 @default.
• W1992418905 hasConceptScore W1992418905C194409129 @default.
• W1992418905 hasConceptScore W1992418905C2776063141 @default.
• W1992418905 hasConceptScore W1992418905C2776364478 @default.
• W1992418905 hasConceptScore W1992418905C2778248108 @default.
• W1992418905 hasConceptScore W1992418905C2778805511 @default.
• W1992418905 hasConceptScore W1992418905C2779703530 @default.
• W1992418905 hasConceptScore W1992418905C2781404941 @default.
• W1992418905 hasConceptScore W1992418905C2993853449 @default.
• W1992418905 hasConceptScore W1992418905C41008148 @default.
• W1992418905 hasConceptScore W1992418905C512399662 @default.
• W1992418905 hasConceptScore W1992418905C71924100 @default.
• W1992418905 hasIssue "9" @default.
• W1992418905 hasLocation W19924189051 @default.
• W1992418905 hasLocation W19924189052 @default.
• W1992418905 hasOpenAccess W1992418905 @default.
• W1992418905 hasPrimaryLocation W19924189051 @default.
• W1992418905 hasRelatedWork W2016819303 @default.
• W1992418905 hasRelatedWork W2017994788 @default.
• W1992418905 hasRelatedWork W2089471205 @default.
• W1992418905 hasRelatedWork W2102686764 @default.
• W1992418905 hasRelatedWork W2419220958 @default.
• W1992418905 hasRelatedWork W2554996381 @default.
• W1992418905 hasRelatedWork W2573866523 @default.
• W1992418905 hasRelatedWork W2991025977 @default.
• W1992418905 hasRelatedWork W3083212577 @default.
• W1992418905 hasRelatedWork W2336950759 @default.
• W1992418905 hasVolume "83" @default.
• W1992418905 isParatext "false" @default.
• W1992418905 isRetracted "false" @default.
• W1992418905 magId "1992418905" @default.
• W1992418905 workType "article" @default.